Clinical Significance and Properties of IFN-γ+IL-17+ Th17 Cells in Liver Injury Associated with Chronic Hepatitis B Virus Infection

Introduction: Our previous study demonstrated that intrahepatic Th17 cells exacerbated the progression of chronic hepatitis B virus (HBV) infection. Meanwhile, we found a small group of IFN-γ and IL-17 double-positive Th17 cells (IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells) in liver tissues. This study aimed to investigate the clinical significance and properties of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells in liver injury associated with chronic HBV infection. Methods: The frequencies of CD4<sup>+</sup> Th cells, Tregs, and CD4<sup>+</sup> T cells expressing specific chemokine receptors in the blood and liver tissues were detected using flow cytometry. The chemotaxis of C C chemokine receptor 5 (CCR5) and C-X-C chemokine receptor 3 (CXCR3) toward IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells and Tregs was evaluated by transwell chemotactic assay. Analyses of different variables were performed using GraphPad Prism v 5.01 and IBM SPSS Statistics 23.0. HBV-specific IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells were investigated using a cell stimulation assay with HBV antigens in vitro. Results: The frequencies of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17, Th17 cells, and Tregs in the blood were increased from normal controls to chronic hepatitis B (CHB) and acute-on-chronic liver failure (ACLF). The same trend could also be observed in CHB liver tissues compared to those in CHB blood specimens. Furthermore, the frequencies of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells were positively associated with Th17 cells, Th17 cell-related cytokines (IL-17 and IL-6), HBV DNA load, and the levels of HBsAg, HBeAg, and ALT. The ratios of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells to Tregs extremely decreased in ACLF blood specimens compared with those in CHB blood specimens. Additionally, CCR5 and CXCR3 were conducive to the recruitment of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells and Tregs to liver tissue. Conclusions: IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells have Th17 cell-like properties in the progression of chronic HBV infection. CCR5 and CXCR3 facilitated the recruitment of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells and Tregs to the liver. Importantly, the ratio of IFN-γ<sup>+</sup>IL-17<sup>+</sup> Th17 cells to Tregs might be an effective assessment indicator of the severity of liver injury.

[1]  Q. Zhan,et al.  Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen‐activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection , 2020, Journal of viral hepatitis.

[2]  Yu-xian Huang,et al.  Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure , 2020, BMC Gastroenterology.

[3]  P. Linsley,et al.  The human tissue-resident CCR5+ T cell compartment maintains protective and functional properties during inflammation , 2019, Science Translational Medicine.

[4]  A. Nadeem,et al.  CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. , 2019, Cellular signalling.

[5]  G. Tonon,et al.  Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression , 2018, Nature Communications.

[6]  Cinque S. Soto,et al.  Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure , 2018, Proceedings of the National Academy of Sciences.

[7]  Roger Williams,et al.  Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B. , 2018, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  N. Tsuji,et al.  Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients. , 2018, Clinics and research in hepatology and gastroenterology.

[9]  C. Creighton,et al.  IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer , 2018, Cancer Immunology Research.

[10]  R. Turner,et al.  Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans , 2018, The Journal of infectious diseases.

[11]  T. Guo,et al.  Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients. , 2017, Clinics and research in hepatology and gastroenterology.

[12]  Wei Gao,et al.  Th17/Treg imbalance and increased interleukin‐21 are associated with liver injury in patients with chronic severe hepatitis B , 2017, International immunopharmacology.

[13]  A. Aghamohammadi,et al.  Abnormality of regulatory T cells in common variable immunodeficiency. , 2017, Cellular immunology.

[14]  L. Brockmann,et al.  Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis , 2017, International journal of molecular sciences.

[15]  F. Tacke,et al.  Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.

[16]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[17]  M. Yousefi,et al.  T Helper 1 (Th1), Th2, and Th17 Responses to Leishmania major Lipophosphoglycan 3 , 2016, Immunological investigations.

[18]  A. Waisman,et al.  Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. , 2016, Cancer cell.

[19]  A. Bertoletti,et al.  Adaptive immunity in HBV infection. , 2016, Journal of hepatology.

[20]  F. Novelli,et al.  The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. , 2016, Clinical science.

[21]  Frank Tacke,et al.  Immunology in the liver — from homeostasis to disease , 2016, Nature Reviews Gastroenterology &Hepatology.

[22]  H. Hermanns,et al.  Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver , 2016, The Journal of Immunology.

[23]  B. Bernstein,et al.  Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation , 2015, Nature.

[24]  D. Bentrem,et al.  Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer , 2015, Cancer Immunology, Immunotherapy.

[25]  Z. Tian,et al.  Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B , 2015, Innate immunity.

[26]  S. Friedman,et al.  IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner , 2014, The Journal of Immunology.

[27]  Roger Williams,et al.  Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption. , 2014, Viral immunology.

[28]  Zheng Zhang,et al.  Pathological functions of interleukin‐22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment , 2014, Hepatology.

[29]  M. Geuking,et al.  Pathological bacterial translocation in liver cirrhosis. , 2014, Journal of hepatology.

[30]  F. Pallone,et al.  Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad , 2013, International reviews of immunology.

[31]  M. Kelly,et al.  Memory CD4+ T Cells Are Required for Optimal NK Cell Effector Functions against the Opportunistic Fungal Pathogen Pneumocystis murina , 2013, The Journal of Immunology.

[32]  Z. Zou,et al.  Increased Th17 cells contribute to disease progression in patients with HBV‐associated liver cirrhosis , 2012, Journal of viral hepatitis.

[33]  Z. Ying,et al.  Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection , 2012, BMC Gastroenterology.

[34]  D. Adams,et al.  T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6. , 2012, European urology.

[35]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[36]  C. Trautwein,et al.  Functional role of chemokines in liver disease models , 2010, Nature Reviews Gastroenterology &Hepatology.

[37]  Thomas Korn,et al.  Proinflammatory T helper type 17 cells are effective B-cell helpers , 2010, Proceedings of the National Academy of Sciences.

[38]  Haiyang Xie,et al.  Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B , 2010, Journal of Clinical Immunology.

[39]  Jiyuan Zhang,et al.  Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B , 2010, Hepatology.

[40]  R. D. Hatton,et al.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective , 2009, Nature Reviews Immunology.

[41]  L. Coussens,et al.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.

[42]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[43]  Irma Joosten,et al.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. , 2008, Blood.

[44]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[45]  P. Hillsamer,et al.  Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells1 , 2008, The Journal of Immunology.

[46]  A. Neumann,et al.  Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity , 2007, Antimicrobial Agents and Chemotherapy.

[47]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[48]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[49]  Xuexian O Yang,et al.  Chromatin Remodeling of Interleukin-17 (IL-17)-IL-17F Cytokine Gene Locus during Inflammatory Helper T Cell Differentiation* , 2007, Journal of Biological Chemistry.

[50]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[51]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[53]  E. Kunkel,et al.  Rules of chemokine receptor association with T cell polarization in vivo. , 2001, The Journal of clinical investigation.

[54]  H. Weiner,et al.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.